ABOUT US

ABOUT US


Despite major progress over the last 50 years (80% of young people with malignancy are disease free at 5 years after diagnosis), cancer remains the most common cause of death by disease beyond the age of one.


"There is a need to accelerate the process of evaluating innovative therapies and introducing them in standard cancer care in children and adolescents." Gilles Vassal, ACCELERATE Chair

Find out more

ACCELERATE is unique:

It guarantees the involvement of the four stakeholder groups (academia, patient advocates, industry and regulators) as equal partners

It Is patient-centred and problem-solving

It is international, having more than thousand experts and advocates having participated in its initiatives

Find out more

Sponsors & Testimonials


Find out more
Share by: